{"id":401096,"date":"2020-12-16T10:37:32","date_gmt":"2020-12-16T15:37:32","guid":{"rendered":"http:\/\/www.marketnewsdesk.com\/?p=401096"},"modified":"2020-12-16T10:37:32","modified_gmt":"2020-12-16T15:37:32","slug":"emerging-markets-report-doctors-orders","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/","title":{"rendered":"Emerging Markets Report: Doctor\u2019s Orders"},"content":{"rendered":"

\nAn Emerging Markets News Commentary
\n<\/h2>\n
\n

ORLANDO, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) — It\u2019s been a little while since we published regarding Grey Cloak Tech Inc., (OTCQB: GRCK)<\/strong>\u00a0soon to be\u00a0Healthy Extracts Inc.<\/a>, \u00a0a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products.<\/p>\n

It was worth the wait.<\/p>\n

A short while ago, Grey Cloak announced its subsidiary\u00a0BergaMet<\/a> NA<\/a> has entered into an exclusive performance-driven agreement with\u00a0Xymogen<\/a>\u00ae<\/sup><\/a>\u00a0to purchase BergaMet\u2019s<\/a>\u00a0Citrus Bergamot\u00a0<\/a>SuperFruit<\/a>\u2122<\/a>.<\/p>\n

Xymogen\u2019s is a major account for Grey Cloak and the new deal is a very big deal for the Company, taking over three years to consummate. Essentially, it\u2019s the sale of Bergamet\u2019s Citrus Bergamot SuperFruit\u2122 specifically formulated to combat cardiovascular disease, metabolic syndrome and nonalcoholic fatty liver disease.\u00a0<\/p>\n

Those are vast markets if you\u2019re wondering.<\/p>\n

Reading through the presser, one line stood out even beyond the headline:<\/p>\n

\n \u201cXymogen is now selling and distributing its proprietary formulations of their\u00a0<\/em>
\n
\n BergaCor\u2122<\/em>
\n <\/a>
\n \u00a0and\u00a0<\/em>
\n
\n BergaCorPlus<\/em>
\n <\/a>
\n
\n \u2122<\/em>
\n <\/a>
\n \u00a0to their 20,000- plus medical doctor network.\u201d<\/em>\n <\/p>\n

\n
\n Twenty-thousand doctors.<\/u>
\n <\/strong>\n <\/p>\n

That\u2019s an incredible network of influence and obviously, doctors likely represent an exponential number of patients to whom they can refer the products. That could be powerful.<\/p>\n

Time will tell through Q\u2019s and K\u2019s but it will be very interesting to see how many Doctor\u2019s Orders will turn into Doctor\u2019s Orders<\/em>.<\/p>\n

\n About Grey Cloak Tech Inc.<\/strong>\n <\/p>\n

Grey Cloak Tech Inc. (OTCQB: GRCK \u2013 name change pending to Healthy Extracts Inc.), through its two subsidiaries, BergaMet NA and Ultimate Brain Nutrients (\u201cUBN\u201d), is engaged in proprietary research and development of natural plant-based formulations, as well as sales and distribution of natural ingredient cardiovascular and neuro products. For more information, visit the company\u2019s websites:
www.HealthyExtractsinc.com<\/a>,\u00a0www.GreyCloakTech.com<\/a>,\u00a0www.BergametNA.com<\/a>,\u00a0www.UBNutrients.com<\/a>.<\/p>\n

\n About The Emerging Markets Report:<\/strong>\n <\/p>\n

\n The Emerging Markets Report<\/em> is owned and operated by Emerging Markets Consulting (EMC), a syndicate of investor relations consultants representing years of experience. Our network consists of stockbrokers, investment bankers, fund managers, and institutions that actively seek opportunities in the micro and small-cap equity markets.<\/p>\n

For more informative reports such as this, please sign up at http:\/\/www.emergingmarketsllc.com\/newsletter.php<\/a><\/p>\n

Section 17(b) of the Securities Act of 1933 requires that any person that uses the mails to publish, give publicity to, or circulate any publication or communication that describes a security in return for consideration received or to be received directly or indirectly from an issuer, underwriter, or dealer, must fully disclose the type of consideration (i.e. cash, free trading stock, restricted stock, stock options, stock warrants) and the specific amount of the consideration. In connection therewith, EMC has received the following compensation and\/or has an agreement to receive in the future certain compensation, as described below.<\/p>\n

We may purchase Securities of the Profiled Company prior to their securities becoming publicly traded, which we may later sell publicly before, during or after our dissemination of the Information, and make profits therefrom. EMC does not verify or endorse any medical claims for any of its client companies.<\/strong><\/p>\n

EMC has been paid $22,500 by Grey Cloak Tech Inc. for various marketing services including this report. EMC does not independently verify any of the content linked-to from this editorial.<\/p>\n

\n http:\/\/emergingmarketsllc.com\/disclaimer.php<\/a>\n <\/p>\n

\n Emerging Markets Consulting, LLC
<\/strong>Florida Office
390 N Orange Avenue Suite 2300
Orlando, FL 32801
E-mail: jamespainter@emergingmarketsllc.com<\/a>
Web: www.emergingmarketsllc.com<\/a>\u00a0<\/p>\n<\/p>\n


\n
\n \n <\/div>\n

<\/div>\n","protected":false},"excerpt":{"rendered":"

An Emerging Markets News Commentary ORLANDO, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) — It\u2019s been a little while since we published regarding Grey Cloak Tech Inc., (OTCQB: GRCK)\u00a0soon to be\u00a0Healthy Extracts Inc., \u00a0a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products. It was worth the wait. A short while ago, Grey Cloak announced its subsidiary\u00a0BergaMet NA has entered into an exclusive performance-driven agreement with\u00a0Xymogen\u00ae\u00a0to purchase BergaMet\u2019s\u00a0Citrus Bergamot\u00a0SuperFruit\u2122. Xymogen\u2019s is a major account for Grey Cloak and the new deal is a very big deal for the Company, taking over three years to consummate. Essentially, it\u2019s the sale of Bergamet\u2019s Citrus Bergamot SuperFruit\u2122 specifically formulated to combat cardiovascular … <\/p>\n

Continue reading “Emerging Markets Report: Doctor\u2019s Orders”<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-401096","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"\nEmerging Markets Report: Doctor\u2019s Orders - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Emerging Markets Report: Doctor\u2019s Orders - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"An Emerging Markets News Commentary ORLANDO, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) — It\u2019s been a little while since we published regarding Grey Cloak Tech Inc., (OTCQB: GRCK)\u00a0soon to be\u00a0Healthy Extracts Inc., \u00a0a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products. It was worth the wait. A short while ago, Grey Cloak announced its subsidiary\u00a0BergaMet NA has entered into an exclusive performance-driven agreement with\u00a0Xymogen\u00ae\u00a0to purchase BergaMet\u2019s\u00a0Citrus Bergamot\u00a0SuperFruit\u2122. Xymogen\u2019s is a major account for Grey Cloak and the new deal is a very big deal for the Company, taking over three years to consummate. Essentially, it\u2019s the sale of Bergamet\u2019s Citrus Bergamot SuperFruit\u2122 specifically formulated to combat cardiovascular … Continue reading "Emerging Markets Report: Doctor\u2019s Orders"\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2020-12-16T15:37:32+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Emerging Markets Report: Doctor\u2019s Orders\",\"datePublished\":\"2020-12-16T15:37:32+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/\"},\"wordCount\":584,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/\",\"name\":\"Emerging Markets Report: Doctor\u2019s Orders - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==\",\"datePublished\":\"2020-12-16T15:37:32+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/emerging-markets-report-doctors-orders\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Emerging Markets Report: Doctor\u2019s Orders\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Emerging Markets Report: Doctor\u2019s Orders - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/","og_locale":"en_US","og_type":"article","og_title":"Emerging Markets Report: Doctor\u2019s Orders - Market Newsdesk","og_description":"An Emerging Markets News Commentary ORLANDO, Fla., Dec. 16, 2020 (GLOBE NEWSWIRE) — It\u2019s been a little while since we published regarding Grey Cloak Tech Inc., (OTCQB: GRCK)\u00a0soon to be\u00a0Healthy Extracts Inc., \u00a0a company engaged in the proprietary development of natural plant-based formulations as well as sales and distribution of cardiovascular and neuro products. It was worth the wait. A short while ago, Grey Cloak announced its subsidiary\u00a0BergaMet NA has entered into an exclusive performance-driven agreement with\u00a0Xymogen\u00ae\u00a0to purchase BergaMet\u2019s\u00a0Citrus Bergamot\u00a0SuperFruit\u2122. Xymogen\u2019s is a major account for Grey Cloak and the new deal is a very big deal for the Company, taking over three years to consummate. Essentially, it\u2019s the sale of Bergamet\u2019s Citrus Bergamot SuperFruit\u2122 specifically formulated to combat cardiovascular … Continue reading \"Emerging Markets Report: Doctor\u2019s Orders\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/","og_site_name":"Market Newsdesk","article_published_time":"2020-12-16T15:37:32+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Emerging Markets Report: Doctor\u2019s Orders","datePublished":"2020-12-16T15:37:32+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/"},"wordCount":584,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/","name":"Emerging Markets Report: Doctor\u2019s Orders - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==","datePublished":"2020-12-16T15:37:32+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODExMzM2MCMzODg0NTczIzUwMDA3NDgyOQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/emerging-markets-report-doctors-orders\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Emerging Markets Report: Doctor\u2019s Orders"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=401096"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/401096\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=401096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=401096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=401096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}